Literature DB >> 10864191

Time between sputum examination and treatment in patients with smear-negative pulmonary tuberculosis.

F M Salaniponi1, F Gausi, J H Kwanjana, A D Harries.   

Abstract

The time between sputum examination and commencement of treatment in patients registered with smear-negative pulmonary tuberculosis (PTB) in four hospitals in Malawi was investigated. Information was obtained in 701 of 887 patients who were registered over a 12-month period between 1997 and 1998: 86% were started on treatment within 3 weeks of sputum examination, 14% were started after a 3-week interval and 6% after a 6-week interval. Such delays are unacceptable, for a number of reasons. Recommendations will go to programme staff to repeat sputum examination in PTB suspects with an abnormal chest radiograph whose negative sputum smears were examined more than 3 weeks previously.

Entities:  

Mesh:

Year:  2000        PMID: 10864191

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Sputum smear examination and time to diagnosis in patients with smear-negative pulmonary tuberculosis in the Pacific.

Authors:  K Viney; K Bissell; K Tabutoa; T Kienene; N N Linh; K Briand; A D Harries
Journal:  Public Health Action       Date:  2012-10-30

2.  Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings.

Authors:  Jonathan G Peter; Grant Theron; Nevanda Singh; Avani Singh; Keertan Dheda
Journal:  Eur Respir J       Date:  2013-03-21       Impact factor: 16.671

3.  Patient and heath system delays in the diagnosis and treatment of new and retreatment pulmonary tuberculosis cases in Malawi.

Authors:  Lumbani Makwakwa; Mei-ling Sheu; Chen-Yuan Chiang; Shoei-Loong Lin; Peter W Chang
Journal:  BMC Infect Dis       Date:  2014-03-10       Impact factor: 3.090

4.  Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?

Authors:  Natasha F Sabur; Aliasgar Esmail; Mantaj S Brar; Keertan Dheda
Journal:  BMC Infect Dis       Date:  2017-12-28       Impact factor: 3.090

5.  Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013.

Authors:  Kudakwashe C Takarinda; Charles Sandy; Nyasha Masuka; Patrick Hazangwe; Regis C Choto; Tsitsi Mutasa-Apollo; Brilliant Nkomo; Edwin Sibanda; Owen Mugurungi; Anthony D Harries; Nicholas Siziba
Journal:  Tuberc Res Treat       Date:  2017-03-02

6.  Survival among patients with HIV infection and smear-negative pulmonary tuberculosis - United States, 1993-2006.

Authors:  J Sean Cavanaugh; N Sarita Shah; Kevin P Cain; Carla A Winston
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.